Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cobiprostone for prevention of NSAID-induced gastroduodenal injury in OA/RA
NCT00597818Phase 2Completed
- Sponsor
- Sucampo
- Start
- Aug 2007
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cobiprostone in NSAID-induced gastroduodenal injury, sponsored by Sucampo. Started Aug 2007; status: completed.
02
Drugs
cobiprostone
03
Conditions
NSAID-induced gastroduodenal injury
Beyond the preview
Go deeper on NCT00597818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00597818.